2017 Guidelines of The Korean Association of Urogenital Tract Infection and Inflammation: Recurrent Urinary Tract Infection

키워드

참고문헌 (54)

1. Fowler JE Jr, "Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study", N Engl J Med, 304, pp.462~465 (1981)
2. Foxman B, "Risk factors for second urinary tract infection among college women", Am J Epidemiol, 151, pp.1194~1205 (2000)
3. Ikaheimo R, "Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179women", Clin Infect Dis, 22, pp.91~99 (1996)
4. Kraft JK, "The natural history of symptomatic recurrent bacteriuria in women", Medicine (Baltimore), 56, pp.55~60 (1977)
5. Stamm WE, "Natural history of recurrent urinary tract infections in women", Rev Infect Dis, 13, pp.77~84 (1991)
6. Berry RE, "Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli", Infect Immun, 77, pp.2762~2772 (2009)
7. Mulvey MA, "Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection", Infect Immun, 69, pp.4572~4579 (2001)
8. Rosen DA, "Detection of intracellular bacterial communities in human urinary tract infection", PLoS Med, 4, pp.e329~ (2007)
9. van Haarst EP, "Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections", Urology, 57, pp.1068~1072 (2001)
10. Scholes D, "Risk factors for recurrent urinary tract infection in young women", J Infect Dis, 182, pp.1177~1182 (2000)
11. Foxman B, "Health behavior and urinary tract infection in college-aged women", J Clin Epidemiol, 43, pp.329~337 (1990)
12. Semins MJ, "The impact of obesity on urinary tract infection risk", Urology, 79, pp.266~269 (2012)
13. Perrotta C, "Oestrogens for preventing recurrent urinary tract infection in postmenopausal women", Obstet Gynecol, 112, pp.689~690 (2008)
14. Brostrøm S, "Oestrogen for prevention of recurrent urinary tract infections in postmenopausal women--a survey of a Cochrane review", Ugeskr Laeger, 171, pp.2568~2571 (2009)
15. Raz R, "A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections", N Engl J Med, 329, pp.753~756 (1993)
16. Eriksen B, "A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring)on recurrent urinary tract infections in postmenopausal women", Am J Obstet Gynecol, 180, pp.1072~1079 (1999)
17. Albert X, "Antibiotics for preventing recurrent urinary tract infection in non-pregnant women", Cochrane Database Syst Rev, (3), pp.CD001209~ (2004)
18. Schaeffer AJ, "Efficacy and safety of self-start therapy in women with recurrent urinary tract infections", J Urol, 161, pp.207~211 (1999)
19. Gupta K, "Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women", Ann Intern Med, 135, pp.9~16 (2001)
20. Wong ES, "Management of recurrent urinary tract infections with patient-administered single-dose therapy", Ann Intern Med, 102, pp.302~307 (1985)
21. Gupta K, "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women:A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases", Clin Infect Dis, 52, pp.e103~e120 (2011)
22. Stapleton A, "Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial", JAMA, 264, pp.703~706 (1990)
23. Melekos MD, "Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women", J Urol, 157, pp.935~939 (1997)
24. Guibert J, "Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin", Presse Med, 24, pp.213~216 (1995)
25. Cetti RJ, "The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: a recent medico-legal case", BJU Int, 103, pp.567~569 (2009)
26. Howell AB, "Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study", BMC Infect Dis, 10, pp.94~ (2010)
27. Lavigne JP, "In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules", Clin Microbiol Infect, 14, pp.350~355 (2008)
28. Schmidt DR, "An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates", Microbios, 55, pp.173~181 (1988)
29. Kontiokari T, "Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women", BMJ, 322, pp.1571~ (2001)
30. Stothers L., "A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women", Can J Urol, 9, pp.1558~1562 (2002)
31. Barbosa-Cesnik C, "Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial", Clin Infect Dis, 52, pp.23~30 (2011)
32. Ochoa-Brust GJ, "Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy", Acta Obstet Gynecol Scand, 86, pp.783~787 (2007)
33. Carlsson S, "In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria", Antimicrob Agents Chemother, 47, pp.3713~3718 (2003)
34. Carlsson S, "Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine", Nitric Oxide, 5, pp.580~586 (2001)
35. Brumfitt W, "Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate", J Urol, 126, pp.71~74 (1981)
36. Brumfitt W, "Long-term prophylaxis of urinary infections in women:comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine", J Urol, 130, pp.1110~1114 (1983)
37. Cronberg S, "Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study", Br Med J (Clin Res Ed), 294, pp.1507~1508 (1987)
38. Gundersen R, "Frequent cystitis in elderly women. A double-blind comparison of Hiprex and placebo in general practice", Tidsskr Nor Laegeforen, 106, pp.2048~2049 (1986)
39. Hoivik HO, "Prevention of recurrent cystitis in fertile women. A double-blind comparison of Hiprex and placebo in general practice", Tidsskr Nor Laegeforen, 104, pp.1150~1152 (1984)
40. Lee BS, "Methenamine hippurate for preventing urinary tract infections", Cochrane Database Syst Rev, 10, pp.CD003265~ (2012)
41. Michaels EK, "Effect of D-mannose and D-glucose on Escherichia coli bacteriuria in rats", Urol Res, 11, pp.97~102 (1983)
42. Wellens A, "Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex", PLoS One, 3, pp.e2040~ (2008)
43. Felipe I, "Inhibition of macrophage phagocytosis of Escherichia coli by mannose and mannan", Braz J Med Biol Res, 24, pp.919~924 (1991)
44. van der Bosch JF, "Mannose-sensitive and mannose-resistant adherence to human uroepithelial cells and urinary virulence of Escherichia coli", Infect Immun, 29, pp.226~233 (1980)
45. Anukam KC, "Clinical study comparing probiotic Lactobacillus GR-1and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis", Microbes Infect, 8, pp.2772~2776 (2006)
46. Wagenlehner FM, "Prevention of recurrent urinary tract infections", Minerva Urol Nefrol, 65, pp.9~20 (2013)
47. Stapleton AE, "Randomized, placebo-controlled phase 2trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection", Clin Infect Dis, 52, pp.1212~1217 (2011)
48. Damiano R, "Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial", Eur Urol, 59, pp.645~651 (2011)
49. Naber KG, "Immunoactive prophylaxis of recurrent urinary tract infections: a metaanalysis", Int J Antimicrob Agents, 33, pp.111~119 (2009)
50. Bauer HW, "Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled doubleblind studies", Int J Antimicrob Agents, 19, pp.451~456 (2002)
51. Bauer HW, "A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections", Eur Urol, 47, pp.542~548 (2005)
52. 김건석, "A Prospective Multi-center Trial of Escherichia coli Extract for the Prophylactic Treatment of Patients with Chronically Recurrent Cystitis", Journal of Korean Medical Science, 25(3), pp.435~439 (2010), 대한의학회
53. Ha US, "Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections", Int J Antimicrob Agents, 31(Suppl 1), pp.S63~S67 (2008)
54. Uehling DT, "Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections", J Urol, 170, pp.867~869 (2003)

관련 논문AI추천